|
GTF2H2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.556720E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.842000E-04 |
| Normal-vs-Stage2 |
9.760300E-03 |
| Normal-vs-Stage3 |
2.983400E-04 |
| Normal-vs-Stage4 |
3.52200000000025E-05 |
| Stage1-vs-Stage2 |
6.684800E-01 |
| Stage1-vs-Stage3 |
4.395000E-01 |
| Stage1-vs-Stage4 |
1.222160E-01 |
| Stage2-vs-Stage3 |
4.097400E-01 |
| Stage2-vs-Stage4 |
1.263770E-01 |
| Stage3-vs-Stage4 |
4.813000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93987000000062E-05 |
| Normal-vs-AfricanAmerican |
1.324330E-02 |
| Normal-vs-Asian |
1.93681999999251E-05 |
| Caucasian-vs-AfricanAmerican |
9.424600E-01 |
| Caucasian-vs-Asian |
9.753800E-02 |
| AfricanAmerican-vs-Asian |
3.527800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21990000000005E-05 |
| Normal-vs-Female |
2.804200E-04 |
| Male-vs-Female |
3.872000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.765700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.61561999999504E-05 |
| Normal-vs-Age(61-80Yrs) |
3.766200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.026000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.312800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.920000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.051600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.116000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.663800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.326000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.990200E-02 |
| Classical-VS-Follicular |
2.099000E-01 |
| Classical-VS-Other |
4.173400E-01 |
| Classical-VS-Normal |
1.61804999999626E-05 |
| Tall-VS-Follicular |
1.917640E-02 |
| Tall-VS-Other |
1.141950E-01 |
| Tall-VS-Normal |
1.215530E-04 |
| Follicular-VS-Other |
6.872600E-01 |
| Follicular-VS-Normal |
7.155200E-03 |
| Other-VS-Normal |
3.894000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.997110E-04 |
| Normal-vs-N1 |
8.16310000040232E-07 |
| N0-vs-N1 |
6.259400E-03 |
|
|
